| 2BOU | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | BA, CA, CAC | enzyme |
| ||||||||||||
| note | 2BOU is a representative structure | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Crystallization and preliminary X-ray diffraction analysis of three EGF domains of EMR2, a 7TM immune-system molecule., Abbott RJ, Knott V, Roversi P, Neudeck S, Lukacik P, Handford PA, Lea SM, Acta Crystallogr D Biol Crystallogr. 2004 May;60(Pt 5):936-8. Epub 2004, Apr 21. PMID:15103144 | ||||||||||||||
| Data retrieval |
![]() |
| View 2BOU in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |